Aflac Stock Forecast for 2023 - 2025 - 2030
Updated on 04/18/2024
Aflac Stock Forecast and Price Target
Aflac has an average price target of $84.00 recently offered by notable experts for 2024, which would represent a potential upside of approximately 3.73% from the last closing price in April, 2024 if reached. This potential increase is based on a high estimate of $100.00 and a low estimate of $75.00. If you're looking for information on Aflac stock, consider checking out the forecasts for comparable firms such as NYSE:CNO.
3.73% Upside
Aflac Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Aflac's Price has fallen from $54.27 to $0.00 – a 100.00% decrease. In the next year, analysts predict that Fair Value will jump to $64.86 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BRK.A Stock Forecast | Berkshire Hathaway Inc | Outperform |
7
|
$604.14k | Buy/Sell | $621.67k | 6.76% |
| JPM Stock Forecast | JPMorgan Chase | Outperform |
12
|
$181.25 | Buy/Sell | $192.32 | 17.52% |
| WFC Stock Forecast | Wells Fargo & | Outperform |
8
|
$58.74 | Buy/Sell | $55.70 | 5.55% |
| ELV Stock Forecast | Elevance Health | Buy |
14
|
$525.19 | Buy/Sell | $567.53 | 11.39% |
| BLK Stock Forecast | BlackRock | Outperform |
15
|
$747.30 | Buy/Sell | $883.74 | 22.11% |
Aflac Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Aflac's Revenue has fallen from $22.15B to $18.70B – a 15.56% decrease. In the next year, analysts predict that Revenue will jump to $19.65B – up 5.06% from the current level. Looking ahead to seven years, experts forecast that Revenue will grow by 7.47%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CB Stock Forecast | Chubb | Outperform |
8
|
$245.39 | Buy/Sell | $243.68 | 10.03% |
| CI Stock Forecast | The Cigna Group | Outperform |
12
|
$348.78 | Buy/Sell | $354.48 | 10.38% |
| CS Stock Forecast | AXA | Outperform |
10
|
33.82€ | Buy/Sell | 32.17€ | 9.40% |
.jpg)
Aflac Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Aflac's Dividend per Share has seen an increase, rising from $1.12 to $1.68. This represents a growth of 50.00%. Analysts predict that Aflac's Dividend per Share will increase in the upcoming year, reaching $1.91. This would represent an increase of 13.69%. Over the next seven years, experts predict that Aflac's Dividend per Share will grow at a rate of 29.87%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 8766 Stock Forecast | Tokio Marine Holdings | Outperform |
4
|
¥4.67k | Buy/Sell | ¥3.51k | 4.67% |
| MET Stock Forecast | MetLife | Outperform |
10
|
$69.95 | Buy/Sell | $77.01 | 18.66% |
| AIG Stock Forecast | American International Group | Outperform |
8
|
$72.99 | Buy/Sell | $76.11 | 13.03% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TRV Stock Forecast | The Travelers Companies | Hold |
8
|
$210.42 | Buy/Sell | $215.98 | 8.35% |
| ALL Stock Forecast | The Allstate | Outperform |
6
|
$169.11 | Buy/Sell | $168.84 | 11.76% |
| AMP Stock Forecast | Ameriprise Financial | Outperform |
10
|
$412.63 | Buy/Sell | $420.39 | 11.48% |
Aflac EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, EBITDA for Aflac has grown by 19.47%, going from $4.44B to $5.31B. In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach $7.57B – an increase of 42.57%. According to professional forecasts, in 2030, Aflac's EBITDA will decrease by 1.74%, reaching $5.21B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MFC Stock Forecast | Manulife Financial | Outperform |
9
|
C$31.59 | Buy/Sell | C$29.66 | 13.96% |
| BK Stock Forecast | The Bank of New York Mellon | Outperform |
8
|
$55.25 | Buy/Sell | $60.55 | 15.84% |
| HUM Stock Forecast | Humana | Outperform |
14
|
$324.83 | Buy/Sell | $426.74 | 19.45% |
Aflac EBIT Forecast for 2023 - 2025 - 2030
Aflac's EBIT has grown in the last three years, jumping from $4.40B to $5.26B – an increase of 19.56%. According to 1 analysts, Aflac's EBIT will fall by 19.84% in the next year, reaching $4.22B. Professionals believe that By 2030, Aflac's EBIT will fall to $4.54B – a 13.66% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PRU Stock Forecast | Prudential Financial | Hold |
8
|
$108.70 | Buy/Sell | $107.07 | 5.80% |
| SLF Stock Forecast | Sun Life Financial | Outperform |
16
|
C$69.80 | Buy/Sell | C$70.85 | 8.88% |
| HIG Stock Forecast | Hartford Financial Services Gr... | Outperform |
18
|
$96.95 | Buy/Sell | $94.55 | 13.46% |
Aflac EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Aflac's EPS has fallen from $4.92 to $0.00 – a 100.00% decrease. In the next year, analysts predict that EPS will jump to $5.88 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TROW Stock Forecast | T Rowe Price Group Inc | Hold |
8
|
$108.72 | Buy/Sell | $104.85 | 3.48% |
| 8750 Stock Forecast | Dai-ichi Life Holdings | Outperform |
16
|
¥3.50k | Buy/Sell | ¥3.29k | 11.30% |
| WRB Stock Forecast | W. R. Berkley | Outperform |
12
|
$80.98 | Buy/Sell | $84.12 | 14.84% |
.jpg)